Central losartan administration increases cardiac workload during aerobic exercise.

Area of Science:

• Cardiovascular Physiology
• Exercise Science
• Pharmacology

Background:

• The renin-angiotensin system plays a role in cardiovascular regulation.
• Angiotensin II AT1 receptors are involved in blood pressure control.
• Central effects of angiotensin II on exercise performance are not fully understood.

Purpose of the Study:

• To investigate the impact of central losartan administration on cardiovascular function and exercise performance in Wistar rats.
• To determine if blocking angiotensin II AT1 receptors centrally affects cardiac workload during aerobic exercise.

Main Methods:

• Wistar rats received intracerebroventricular injections of losartan or saline.
• Cardiovascular parameters (heart rate, arterial pressures, rate pressure product) were measured during treadmill exercise.
• Exercise time and workload were recorded as performance indexes.

Main Results:

• Losartan administration led to a significant increase in heart rate, systolic, and diastolic arterial pressures during exercise.
• The rate pressure product, an indicator of cardiac workload, was elevated in losartan-treated rats.
• Exercise time was reduced by 22% in rats receiving central losartan, indicating impaired performance.

Conclusions:

• Central blockade of angiotensin II AT1 receptors with losartan augments cardiac workload during aerobic exercise.
• This increased cardiac workload is associated with reduced exercise performance (ergolytic effect).
• Central losartan administration negatively impacts exercise capacity by increasing cardiovascular strain.